AI-generated summary
The authors studied whether pretreating skin with a low-fluence erbium:YAG laser or electroporation could increase topical delivery of methotrexate, using lab skin diffusion cells and nude mice. They report that both methods significantly enhanced methotrexate permeation, with the laser having the stronger effect, and that combining them gave higher permeation only at the lower laser fluence. The abstract does not describe photobiomodulation outcomes, and the authors call for further investigation.
- Who or what was studied
- Nude mice and in vitro skin samples used in diffusion cell experiments
- Limits stated in the abstract
- The study used in vitro diffusion cells and an animal model, and the abstract does not report human participants.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.